Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia

NCT01388283 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT01388283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01388283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 1999
Completion date
June 30, 2011
Enrollment
129 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia